Ardelyx Inc (ARDX)
5.785
-0.10
(-1.78%)
USD |
NASDAQ |
Nov 05, 11:20
Ardelyx Revenue (Quarterly): 98.24M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 98.24M |
| June 30, 2024 | 73.22M |
| March 31, 2024 | 46.02M |
| December 31, 2023 | 34.36M |
| September 30, 2023 | 56.39M |
| June 30, 2023 | 22.33M |
| March 31, 2023 | 11.37M |
| December 31, 2022 | 44.18M |
| September 30, 2022 | 4.986M |
| June 30, 2022 | 2.526M |
| March 31, 2022 | 0.468M |
| December 31, 2021 | 1.029M |
| September 30, 2021 | 1.173M |
| June 30, 2021 | 1.313M |
| March 31, 2021 | 6.582M |
| December 31, 2020 | 1.809M |
| September 30, 2020 | 2.713M |
| June 30, 2020 | 1.836M |
| March 31, 2020 | 1.213M |
| December 31, 2019 | 2.25M |
| September 30, 2019 | 3.013M |
| June 30, 2019 | 0.018M |
| March 31, 2019 | |
| December 31, 2018 | 0.085M |
| Date | Value |
|---|---|
| September 30, 2018 | 0.172M |
| June 30, 2018 | 0.03M |
| March 31, 2018 | 2.32M |
| December 31, 2017 | 42.00M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 18.14M |
| March 31, 2015 | 5.883M |
| December 31, 2014 | 6.339M |
| September 30, 2014 | 7.598M |
| June 30, 2014 | 9.137M |
| March 31, 2014 | 8.55M |
| December 31, 2013 | 8.488M |
| September 30, 2013 | 6.593M |
| June 30, 2013 | 7.291M |
| March 31, 2013 | 6.556M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.468M
Minimum
Mar 2022
98.24M
Maximum
Sep 2024
20.70M
Average
3.850M
Median
Revenue (Quarterly) Benchmarks
| Verve Therapeutics Inc | 6.692M |
| United Therapeutics Corp | 748.90M |
| NovaBay Pharmaceuticals Inc | 2.40M |
| Palatin Technologies Inc | 0.35M |
| iBio Inc | 0.175M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.809M |
| Total Expenses (Quarterly) | 96.01M |
| EPS Diluted (Quarterly) | -0.0034 |
| Enterprise Value | 1.305B |
| Gross Profit Margin (Quarterly) | 83.99% |
| Profit Margin (Quarterly) | -0.82% |
| Earnings Yield | -5.42% |
| Normalized Earnings Yield | -5.418 |